GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » Price-to-Free-Cash-Flow

Shenzhen YHLO Biotech Co (SHSE:688575) Price-to-Free-Cash-Flow : N/A (As of Apr. 28, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co Price-to-Free-Cash-Flow?

As of today (2025-04-28), Shenzhen YHLO Biotech Co's share price is ¥14.15. Shenzhen YHLO Biotech Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.03. Hence, Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow or its related term are showing as below:

SHSE:688575' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.44   Med: 38.5   Max: 1107.81
Current: 125.23

During the past 8 years, Shenzhen YHLO Biotech Co's highest Price-to-Free-Cash-Flow Ratio was 1107.81. The lowest was 10.44. And the median was 38.50.

SHSE:688575's Price-to-Free-Cash-Flow is ranked worse than
90.86% of 372 companies
in the Medical Devices & Instruments industry
Industry Median: 27.4 vs SHSE:688575: 125.23

Shenzhen YHLO Biotech Co's Free Cash Flow per Share for the three months ended in Mar. 2025 was ¥-0.04. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥-0.03.

During the past 8 years, Shenzhen YHLO Biotech Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 13.50% per year. The lowest was 13.50% per year. And the median was 13.50% per year.


Shenzhen YHLO Biotech Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen YHLO Biotech Co Price-to-Free-Cash-Flow Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - 10.98 - -

Shenzhen YHLO Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 210.62 - -

Competitive Comparison of Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow falls into.


;
;

Shenzhen YHLO Biotech Co Price-to-Free-Cash-Flow Calculation

Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=14.15/-0.03
=N/A

Shenzhen YHLO Biotech Co's Share Price of today is ¥14.15.
Shenzhen YHLO Biotech Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Shenzhen YHLO Biotech Co  (SHSE:688575) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Shenzhen YHLO Biotech Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen YHLO Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Executives
Song Yong Bo Directors, senior managers
Xiao Yu Jin senior management
Liao Li Sheng Directors, senior managers
Pang Shi Hong senior management
Hu Kun Hui Director
Xia Fu Zhen Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines